U.S. Tobacco Stock News

EMCOR Group has been a strong stock over the past several years, yet current valuation checks suggest the market price may still sit below what its intrinsic value estimate implies. After a very large 5 year return, the key issue is whether today's price fairly reflects the business the company has become. Over the last 5 years, EMCOR Group has delivered a very large total return of about 5.8x, which puts extra focus on whether recent gains have already captured its fundamentals. Growing...

StoneX Group stock just absorbed a 12% hit in a single session, yet the earnings story behind that move is far more complicated than a simple miss or disappointment. You are looking at a financial services platform that produced Q3 net income of US$127.9m and diluted earnings per share of US$1.00, alongside a trailing P/E of 15.4x that sits below the cited US market and industry averages. The market is reacting strongly to a single day of trading. The key question is whether that pullback...

In the second quarter of 2026, Better Home & Finance Holding reported a net loss of US$30.59 million, improved from a US$36.27 million loss a year earlier, and announced that long-time CEO Vishal Garg had stepped down, with board member Daniel Lewis taking over as Interim CEO. Alongside this leadership change, Better amended its broker agreement so that Intuit Credit Karma, rather than Better, will offer Credit Karma’s 140 million-strong U.S. consumer base access to Home Equity Line of...

ICF International (ICFI) just paired its second quarter earnings release with a new US$35 million energy efficiency contract from Entergy Louisiana. Both updates give you fresh data on profit trends and contract momentum. See our latest analysis for ICF International. The recent Entergy Louisiana contract and the second quarter earnings update appear to have coincided with stronger interest in ICF International, with the share price at US$85.31 and a 90 day share price return of 22.55%...

DraftKings stock has had a tough run over the past few years, yet some valuation checks now point to it trading on the cheaper side of the sector. That mix of weak long term returns and pockets of apparent value is what current investors are trying to make sense of. DraftKings shareholders have seen the stock decline 59.4% over the past 5 years, which sets a cautious backdrop for any argument that the current share price already discounts the main risks. Expectations around how profitably...

Vanda Pharmaceuticals stock barely budged after earnings, up about 0.5% to around US$5, even though the quarter underscored how hard the current build out is hitting the income statement. The headline is simple: revenue held around US$50.5m while the Q2 net loss widened to US$62.5m as spending on late stage trials and new launches weighed heavily. Investors came into this print after a tough stretch, with the stock down about 20% over the past month. The key question now is how long the...

Traders nudged Editas Medicine up about 5% today, which looks like a cautious, rather than euphoric, vote on a tricky set of numbers. The stock came into this report under pressure over the past month, so even a small relief move matters. The headline is margin pain meeting revenue progress. Total revenue for the quarter sat at US$11.89 million while the company still reported a loss with basic earnings per share at US$0.15 in the red. The real question now is whether this mix justifies...

Sandisk stock closed down 6.8% at US$1,258.58, capping a tough month for holders after a double digit slide over 30 days. That reaction sits awkwardly next to a quarter where revenue hit US$8.97b and non GAAP earnings per share jumped to US$39.25, both ahead of management guidance. The real focus is not today’s drop but what this earnings release suggests about the multi year arc. Sandisk has moved from losses to a full year of profit and now trades on a trailing P/E of 16.4x, while a...

NASB Financial slipped about 1% today, even though the latest quarter showed the kind of earnings power many regional banks would welcome. Basic earnings per share for Q3 landed at roughly US$1.48 on revenue of about US$24.8 million, contributing to a trailing 12 month P/E of 8.4x that currently sits below the broader US banks sector and wider market. For short term traders the red screen might stand out. For longer term investors the focus is on the sustained profitability and the relatively...

Expedia Group just served up the kind of quarter that usually earns a celebration, yet the stock slipped 4.1% to about US$306 after the report. The gap between the reaction and the results is striking. Revenue for Q2 came in at US$4.3b and adjusted EBITDA margin reached 25.9%, with management confident enough to lift full year margin expansion targets. Investors came into this print after a strong three month run in the stock. Today’s move suggests profit taking and nerves, while the earnings...

Allient just ripped 19.3% higher in a single session, and that kind of move always raises the same question: Is this emotion or earnings talking? Coming into the print, the stock was already on a tear over the past quarter, and the valuation looked stretched on a P/E that sat well above peers. The headline this time is profit power. Quarterly basic earnings per share reached about US$0.62 on revenue of roughly US$153.8m, with trailing net income roughly doubling over the past year and net...

Remitly Global stock jumped 7.7% today to US$25.93. That move came as investors reacted to a quarter that put profitability, not just growth, in the spotlight. Q2 revenue reached US$495 million while net income excluding special items came in at US$205.9 million, which is a sharp shift for a digital remittance platform that has spent years focused on scale. The main story is margin strength. Trailing net profit margin now sits at 16.9%, a significant increase from last year. The key question...

In recent days, Autodesk has attracted heightened investor attention ahead of its 27 August 2026 earnings release, with analysts expecting year-over-year growth in both earnings per share and revenue. This focus on stronger anticipated earnings and sales underscores how closely investors are watching analyst forecasts as a gauge of Autodesk's operating momentum. With analysts projecting meaningful earnings and revenue growth, we'll now examine how this optimism could influence Autodesk's...

Novanta stock just jumped 6.7% in a single session, and that move highlights how emotionally charged this earnings season has become. The market responded to a clear headline of double digit revenue growth in Q2 and an increase to full year guidance. Beneath the excitement, the key drivers were margins and cash. Adjusted gross margin reached 47% and adjusted earnings per share rose at a double digit rate, while free cash flow for the quarter was about US$65 million. For a high multiple...

Why Butterfly Network Stock Is Back on Investors’ Radar Butterfly Network (BFLY) is drawing fresh attention after raising its 2026 revenue outlook to US$119 million to US$123 million and issuing higher guidance for the third quarter following its latest earnings report. See our latest analysis for Butterfly Network. Butterfly Network’s raised guidance and stronger recent earnings sit alongside sharp share price momentum, with the stock posting a 30 day share price return of 9.5% and a 1 year...

With fresh US tariffs on imported polysilicon and new incentives for domestic production, the quiet world of semiconductor materials has suddenly moved to center stage. This policy shift could reshape where critical inputs for chips and solar panels are sourced, which matters for investors watching supply chains and pricing power. This article walks through 3 US semiconductor materials stocks exposed to this news and how each might fit, or might not fit, in a portfolio. The stocks highlighted...

Alpha Teknova stock rose 16.4% to close at US$6.53, capping a strong week for investors who were already sitting on solid short term gains. The market is focusing on one key development above all else. The headline result is that Q2 delivered the highest quarterly revenue in the company’s history, with more than US$12 million in sales and a clear step down in the quarterly net loss. That combination of record revenue and a narrower loss appears to have driven today’s shift in sentiment. The...

AbCellera Biologics jumped 10.3% to US$6.53 today, a sharp move for a stock that came into the print with a mixed recent run, up over the past week but down over the past month. The market is reacting to one thing above all else: the company is leaning hard into a high cash burn and deeper quarterly loss to fund its antibody pipeline, backed by a reported US$567 million cash pile and more than US$675 million of available liquidity. The question now is whether that liquidity cushion really...

Evolus stock just ripped almost 20% higher to US$7.41, and the move is all about one thing. The market is latching onto a margin and profitability turn that feels very different from the company investors watched over the past year. Q2 revenue of US$84.1m, helped by aesthetics demand across toxins and fillers, arrived alongside a third straight quarter of positive adjusted earnings before interest, taxes, depreciation and amortization. That shift in earnings quality is what traders are...

In the second quarter of 2026, Precigen, Inc. reported revenue of US$54.98 million, net income of US$20.07 million, and diluted earnings per share from continuing operations of US$0.05, a sharp turnaround from the prior year’s loss-making period. This profitability was driven largely by rapid uptake of Papsimios, supported by expanded payer coverage to about 315 million US lives and seven-year FDA market exclusivity for adult recurrent respiratory papillomatosis. Next, we will examine how...

Why Universal Health Services Stock Is Back on Investors’ Radar Universal Health Services (UHS) has drawn fresh attention after reporting second quarter 2026 results and confirming completion of a long running share repurchase program that has been in place since July 2014. Both events give investors new information on recent operating performance and capital allocation choices as of late July 2026. Together they frame how you might think about the stock today. See our latest analysis for...

Hudson Technologies shares closed at US$5.66, down about 9% on the day, as investors reacted quickly to a quarter that looked softer on the surface. Q2 2026 net income came in at US$4.9m on US$78.3m of revenue, with gross margin squeezed to 26% as hydrofluorocarbon pricing stayed weak. Short term traders focused on that margin pressure and the earnings step down from last year. Longer term holders will be weighing that hit against a clean balance sheet with US$26m of cash and no debt, as well...

Amtech Systems came into this earnings print with the stock under pressure, down about 30% over the past three months and off 16% over the past month, and the slide accelerated today with a 7% drop to US$14.95. The headline from the quarter is very different to that price action. Revenue reached US$22.4m with roughly 50% gross margins and about US$3.3m of adjusted EBITDA, supported by strong demand for thermal processing equipment tied to artificial intelligence infrastructure. Is Amtech...

Eagle Bancorp Montana stock barely flinched after earnings, ticking up just 1.1% to US$23.94. The headline story instead sits on the income statement. The bank posted Q2 basic earnings per share of US$0.47 on revenue of US$23.8m, which keeps profit generation in focus rather than share price moves. For a regional lender often viewed as a quiet compounder, the more notable signal comes from profitability quality. Net interest margin stood at 4.15%, and recent improvements in non performing...